MW1685A1 - N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents - Google Patents
N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agentsInfo
- Publication number
- MW1685A1 MW1685A1 MW16/85A MW1685A MW1685A1 MW 1685 A1 MW1685 A1 MW 1685A1 MW 16/85 A MW16/85 A MW 16/85A MW 1685 A MW1685 A MW 1685A MW 1685 A1 MW1685 A1 MW 1685A1
- Authority
- MW
- MALAWI
- Prior art keywords
- oxindole
- carboxamides
- disubstituted
- analgesic
- inflammatory agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60735684A | 1984-05-04 | 1984-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
MW1685A1 true MW1685A1 (en) | 1986-09-10 |
Family
ID=24431933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MW16/85A MW1685A1 (en) | 1984-05-04 | 1985-05-03 | N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
Country Status (25)
Country | Link |
---|---|
JP (1) | JPS60243068A (en) |
KR (1) | KR870000497B1 (en) |
AR (1) | AR241159A1 (en) |
BG (2) | BG60208B2 (en) |
CS (1) | CS252828B2 (en) |
DD (1) | DD232916A5 (en) |
EG (1) | EG17193A (en) |
ES (2) | ES8609248A1 (en) |
FI (1) | FI80016C (en) |
HU (1) | HU196057B (en) |
IE (1) | IE851103L (en) |
IN (1) | IN161509B (en) |
MA (1) | MA20424A1 (en) |
MW (1) | MW1685A1 (en) |
MX (1) | MX5839A (en) |
NO (1) | NO163132C (en) |
OA (1) | OA08098A (en) |
PL (2) | PL145416B1 (en) |
PT (1) | PT80375B (en) |
RO (2) | RO94455B (en) |
RU (1) | RU2017729C1 (en) |
SU (1) | SU1468413A3 (en) |
YU (1) | YU44998B (en) |
ZA (1) | ZA853324B (en) |
ZW (1) | ZW7885A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
IL95880A (en) * | 1989-10-13 | 1995-12-31 | Pfizer | Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis |
-
1985
- 1985-04-08 IN IN288/DEL/85A patent/IN161509B/en unknown
- 1985-04-30 YU YU730/85A patent/YU44998B/en unknown
- 1985-04-30 PT PT80375A patent/PT80375B/en unknown
- 1985-05-02 JP JP60095275A patent/JPS60243068A/en active Granted
- 1985-05-02 DD DD85275898A patent/DD232916A5/en not_active IP Right Cessation
- 1985-05-02 IE IE851103A patent/IE851103L/en unknown
- 1985-05-02 EG EG275/85A patent/EG17193A/en active
- 1985-05-02 AR AR300259A patent/AR241159A1/en active
- 1985-05-03 RO RO123678A patent/RO94455B/en unknown
- 1985-05-03 PL PL1985253203A patent/PL145416B1/en unknown
- 1985-05-03 NO NO851774A patent/NO163132C/en not_active IP Right Cessation
- 1985-05-03 PL PL1985257892A patent/PL147508B1/en unknown
- 1985-05-03 FI FI851756A patent/FI80016C/en not_active IP Right Cessation
- 1985-05-03 ZA ZA853324A patent/ZA853324B/en unknown
- 1985-05-03 OA OA58583A patent/OA08098A/en unknown
- 1985-05-03 BG BG070071A patent/BG60208B2/en unknown
- 1985-05-03 ES ES542813A patent/ES8609248A1/en not_active Expired
- 1985-05-03 MA MA20648A patent/MA20424A1/en unknown
- 1985-05-03 MX MX583985A patent/MX5839A/en unknown
- 1985-05-03 KR KR1019850003013A patent/KR870000497B1/en not_active IP Right Cessation
- 1985-05-03 ZW ZW78/85A patent/ZW7885A1/en unknown
- 1985-05-03 MW MW16/85A patent/MW1685A1/en unknown
- 1985-05-03 RO RO118604A patent/RO91141B/en unknown
- 1985-05-04 CS CS853202A patent/CS252828B2/en not_active IP Right Cessation
- 1985-05-04 RU SU853891002A patent/RU2017729C1/en active
- 1985-05-31 HU HU851693A patent/HU196057B/en unknown
-
1986
- 1986-01-27 ES ES551275A patent/ES8707182A1/en not_active Expired
- 1986-05-12 SU SU864027453A patent/SU1468413A3/en active
-
1992
- 1992-07-08 BG BG096583A patent/BG60207B2/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA856387B (en) | Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives | |
AU2748192A (en) | 22-methyl-4-aza-21-nor-5alpha-chol-1-en-3,20-dione and 4,22-dimethyl-4-aza-21-nor-5alpha-chol-1-en-3,20-dione as 5alpha-reductase inhibitors | |
NZ218089A (en) | 7-piperazinyl, 4-oxoquinolines and pharmaceutical compositions | |
GB8521793D0 (en) | Analgesic & anti-inflammatory compositions | |
PH21580A (en) | Analgesic and antiinflammatory 1,3 - diacyl - 2 - oxindole compounds | |
ZA861211B (en) | Analgesic composition | |
ZM785A1 (en) | 1,3-disubstituted oxindoles as analgesic and anti-inflammatory agents | |
NZ217123A (en) | 7-alpha-cephalosporins, pharmaceutical compositions and intermediate compounds | |
ZA861212B (en) | Analgesic composition | |
EP0199235A3 (en) | Phenylalkyl-2,3-dihydrobenzofurans and analogs useful as anti-inflammatory agents | |
ZA853379B (en) | Substituted 1-oxa-dethiachphalosporins as anti-inflammatory and antidegenerative agents | |
PH23498A (en) | 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof | |
ZA851521B (en) | Phenylthiomethyl-6-hydroxy-2,3-dihydrobenzo-pyran and analogs thereof useful as anti-inflammatory agents | |
BR8502769A (en) | ORAL, STABLE AND SPARKLING COMPOSITION | |
NZ214088A (en) | 1,3-diazoles and pharmaceutical compositions | |
ZA854947B (en) | Beta-lactam derivatives as anti-inflammatory and anti-degenerative agents | |
ZA851991B (en) | 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
NZ217248A (en) | Gem-dihalo-1,8-diamino-4-aza-octones and pharmaceutical compositions | |
IT1200931B (en) | TRIAZINIC DERIVATIVES EQUIPPED WITH ANALGESIC, ANTI-PIRETIC AND ANTI-INFLAMMATORY ACTIVITIES | |
MW1685A1 (en) | N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
ZM3185A1 (en) | N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
NZ211052A (en) | 1,3-disubstituted-2-oxindoles as analgesic and anti-inflammatory agents | |
EP0172233A4 (en) | Punaglandins and pharmaceutical use thereof. | |
PH23064A (en) | Quinolizinone compound and pharmaceutical composition comprising the same | |
DE3569472D1 (en) | Pharmaceutical composition, its production and use |